TiOAT is a program for people living with opioid use disorders who have not had success with traditional treatment options like Methadone, Suboxone, or Kadian.
Individuals will be assessed by a physician and if eligible, will receive one or two Dilaudid 8mg tablets (aka dilly 8’s) up to 5 times daily, as needed. Participants may apply for dose increase once stable on the program. They may inject the tablets or they make take them orally. All doses are taken onsite and are witnessed by a staff member.
Participants are encouraged to continue or restart Opioid Agonist Treatment (Methadone or Kadian) while on the program, but it is not a requirement to participate.
This is a pilot program and will be evaluated by the BC Centre on Substance Use. For more details on the TiOAT program, including the referral process, click here:
Purpose:
- Engagement with health care
- Decrease or stop illicit drug use
- Create community and build relationships
- Decrease risk of overdose
- Connection to services
- Stabilize addiction
Criteria:
- Can consent and participate in treatment goals
- Are diagnosed with Severe Opioid Use Disorder with an established history of using opioids, such as fentanyl or heroin
- Have tried Opioid Agonist Treatment in the past (such as Methadone, Suboxone, or Kadian) without success; or, continued to use illicit opioids despite treatment
- History of opioid overdoses
- At high risk for other health conditions related to their substance use, such as HIV, Hepatitis C, infections, or death
- 19 years or older
Referral Process:
- Complete a referral form ;
- Fax completed referral to 250-376-7590;
- Applicants may self-refer by calling 250-682-3223;
- Once referrals are received and processed, the applicant will be scheduled for an intake appointment with the physician
- After the intake is completed and approved, the new participant will be contacted with a start date. If the program is full, the participant will be added to a waitlist.
